Latest news
Is Fiserv Worth Buying Now After Earnings Cuts and a Deep Valuation? - The Globe and MailThe Globe and Mail · Mon, 10 Aug 2026 15:46:36 GMTKulicke and Soffa Swings to Profit, Lifts Guidance as Buybacks Reshape Investment Case - finance.biggo.comfinance.biggo.com · Sun, 09 Aug 2026 18:20:00 GMTShould Ligand Pharmaceuticals’ (LGND) Strong Q2 Profit Rebound and Reaffirmed 2026 Guidance Require Action From Investors? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 15:44:12 GMTEmbecta (EMBC) Stock Jumps On Profit Rebound Despite Lingering Debt Strain - simplywall.stsimplywall.st · Sun, 09 Aug 2026 04:02:58 GMTNippon Seiki (TSE:7287) Stock Price Hinges On Profit Recovery And Margins - simplywall.stsimplywall.st · Sun, 09 Aug 2026 01:49:51 GMTJGC Holdings (TSE:1963) Stock Profits Rebound While Revenue Shrinks - simplywall.stsimplywall.st · Sat, 08 Aug 2026 23:41:41 GMTToyo Engineering (TSE:6330) Stock Value Case Hinges On Earnings Recovery - simplywall.stsimplywall.st · Sat, 08 Aug 2026 23:39:42 GMTAmphastar Pharmaceuticals (AMPH) Stock Rebound Meets Margin Pressure And Valuation Gap - simplywall.stsimplywall.st · Sat, 08 Aug 2026 01:11:15 GMT